GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Ending Cash Position

Biomaxima (WAR:BMX) Ending Cash Position : zł0.73 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Ending Cash Position?

Biomaxima's Ending Cash Position for the quarter that ended in Mar. 2024 was zł0.73 Mil.

Biomaxima's quarterly Ending Cash Position increased from Sep. 2023 (zł1.47 Mil) to Dec. 2023 (zł1.50 Mil) but then declined from Dec. 2023 (zł1.50 Mil) to Mar. 2024 (zł0.73 Mil).

Biomaxima's annual Ending Cash Position increased from Dec. 2021 (zł3.00 Mil) to Dec. 2022 (zł12.91 Mil) but then declined from Dec. 2022 (zł12.91 Mil) to Dec. 2023 (zł1.50 Mil).


Biomaxima Ending Cash Position Historical Data

The historical data trend for Biomaxima's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Ending Cash Position Chart

Biomaxima Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 4.39 3.00 12.91 1.50

Biomaxima Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.08 0.82 1.47 1.50 0.73

Biomaxima Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biomaxima's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12.907+-11.404
=1.50

Biomaxima's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.503+-0.774
=0.73


Biomaxima Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biomaxima's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima (WAR:BMX) Business Description

Traded in Other Exchanges
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines